Sun Pharma to buy remaining stake in Taro Pharma for $347.8 million. Details here Sun Pharmaceutical Industries plans to acquire all outstanding shares of Taro Pharmaceutical Industries for $43 per share in cash, aiming to gain complete control over its subsidiary
